- Home
- INFU vs STXS Comparison
INFU vs STXS Comparison
Compare INFU & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- STXS
- Stock Information
- Founded
- INFU 2005
- STXS 1990
- Country
- INFU United States
- STXS United States
- Employees
- INFU N/A
- STXS N/A
- Industry
- INFU Medical/Dental Instruments
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INFU Health Care
- STXS Health Care
- Exchange
- INFU Nasdaq
- STXS Nasdaq
- Market Cap
- INFU 189.2M
- STXS N/A
- IPO Year
- INFU N/A
- STXS 2004
- Fundamental
- Price
- INFU $8.09
- STXS $2.49
- Analyst Decision
- INFU
- STXS Strong Buy
- Analyst Count
- INFU 0
- STXS 2
- Target Price
- INFU N/A
- STXS $4.50
- AVG Volume (30 Days)
- INFU 85.2K
- STXS 412.8K
- Earning Date
- INFU 03-13-2025
- STXS 03-03-2025
- Dividend Yield
- INFU N/A
- STXS N/A
- EPS Growth
- INFU 60.96
- STXS N/A
- EPS
- INFU 0.07
- STXS N/A
- Revenue
- INFU $132,783,999.00
- STXS $25,143,000.00
- Revenue This Year
- INFU $10.23
- STXS $3.73
- Revenue Next Year
- INFU $8.80
- STXS $54.27
- P/E Ratio
- INFU $115.42
- STXS N/A
- Revenue Growth
- INFU 8.17
- STXS N/A
- 52 Week Low
- INFU $5.74
- STXS $1.66
- 52 Week High
- INFU $9.97
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- INFU 46.37
- STXS 61.67
- Support Level
- INFU $7.99
- STXS $2.26
- Resistance Level
- INFU $8.56
- STXS $2.52
- Average True Range (ATR)
- INFU 0.26
- STXS 0.13
- MACD
- INFU 0.02
- STXS 0.03
- Stochastic Oscillator
- INFU 40.91
- STXS 89.80
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.